LCID
Lucid Group, Inc.
LCID has the edge over ZUMZ overall, supported by stronger valuation and stronger fundamentals.
ZUMZ
Zumiez Inc.
ZUMZ has lower modeled downside risk, despite its lower overall score.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ZUMZ Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
ZUMZ's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
ZUMZ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.1x | $5.19 | -63% |
| Fair | 14x | $8.64 | -39% |
| Current | 22x | $14.09 | — |
| Expensive | 25x | $16.27 | +15% |
| Forward | 34x | $14.09 | — |
Historical ranges are pointers, not guarantees.
ZUMZ's PE is in its expensive range at 22x. On analysts' estimates for next year's earnings, today's price would be 34x.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ZUMZ Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect ZUMZ's earnings to grow, with its revenue and profitability holding steady. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
ZUMZ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.42 | -35% |
| Q3 2026 | $0.64 | +$0.68 |
| Q2 2026 | $0.75 | +$0.77 |
| Q1 2026 | $0.78 | +$0.87 |
| Q4 2025 | $0.45 | +$3.02 |
| Q3 2025 | -$0.04 | +$2.71 |
| Q2 2025 | -$0.02 | +$3.13 |
| Q1 2025 | -$0.09 | +$3.16 |
| Q4 2024 | -$2.57 | -$1.63 |
ZUMZ has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over ZUMZ on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
ZUMZ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $209M | -2.5% |
| Q2 2026 | $193.3M | +4.9% |
| Q1 2026 | $291.3M | +4.4% |
| Q4 2025 | $239.1M | +7.5% |
| Q3 2025 | $214.3M | +1.9% |
| Q2 2025 | $184.3M | +3.9% |
| Q1 2025 | $279.2M | -0.9% |
| Q4 2024 | $222.5M | +2.8% |
ZUMZ's revenue fell from its 2022 peak and has held roughly level since: $209M last quarter, down 2.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.6% | -0.7 points |
| Q2 2026 | -7.9% | +2.9 points |
| Q1 2026 | 8.6% | +1.4 points |
| Q4 2025 | 4.9% | +3.9 points |
| Q3 2025 | 0.1% | +0.2 points |
| Q2 2025 | -11% | +0.6 points |
| Q1 2025 | 7.2% | +19 points |
| Q4 2024 | 1.1% | +1.1 points |
ZUMZ has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
ZUMZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.4M | -125% |
| Q2 2026 | -$29.8M | -$5.5M |
| Q1 2026 | $54.1M | +8.9% |
| Q4 2025 | $3.1M | +$25.4M |
| Q3 2025 | $9.5M | +$10.1M |
| Q2 2025 | -$24.3M | -$3.2M |
| Q1 2025 | $49.7M | +48% |
| Q4 2024 | -$22.3M | -$19.3M |
ZUMZ has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
ZUMZ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.1% | -497K shares |
| 1 year | -5.9% | -990K shares |
| 3 years | -19% | -3.6M shares |
| 5 years | -39% | -9.9M shares |
| Available history | -39% | -9.9M shares |
ZUMZ has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $23M |
| Q2 2026 | $6M |
| Q1 2026 | — |
| Q4 2025 | $5.6M |
| Q3 2025 | $7.5M |
| Q2 2025 | $25.2M |
| Q1 2025 | — |
| Q4 2024 | $5.6M |
ZUMZ spent $35M buying back its own shares over the past year, down 9.8% from the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ZUMZ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -3.4x | Net Cash |
| Q4 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.6x | Net Cash |
| Q1 2025 | -4.7x | Net Cash |
| Q4 2023 | -9.4x | Net Cash |
| Q3 2023 | -3.7x | Net Cash |
ZUMZ has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ZUMZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.8 | Neutral |
| Stochastic | 18.2 | Oversold |
ZUMZ's weekly RSI is 37 (neutral) and its Stochastic is 18 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
ZUMZ PE vs Consumer Cyclical Sector
| Metric | ZUMZ | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 22% above |
| PE % | 76 | 47 | 29 pts above |
ZUMZ is trading at 22x earnings, a 22% premium to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
ZUMZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.1 | 0.2% above |
| 20 week MA | $16.3 | 14% below |
| 50 week MA | $20.9 | 33% below |
| 100 week MA | $18.6 | 24% below |
| 200 week MA | $19.0 | 26% below |
ZUMZ has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
ZUMZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.7 | $36.0 | +10% |
| 2021 | $36.0 | $45.9 | +27% |
| 2022 | $45.9 | $21.0 | -54% |
| 2023 | $21.0 | $20.3 | -3.2% |
| 2024 | $20.3 | $19.5 | -4.3% |
| 2025 | $19.5 | $27.2 | +40% |
| 2026 YTD | $27.2 | $14.1 | -48% |
ZUMZ has the edge over LCID on returns for 2026, with the stronger performance.